• Monday, Sep 27, 2021
  • Last Update : 10:59 am

Singapore approves Remdesivir for emergency Covid-19 treatment

  • Published at 06:49 pm June 10th, 2020
Remdesivir-eskayef
Remdesivir is the first drug shown to be effective against the novel coronavirus in human trials

'Although the data on its efficacy and safety is very limited at this point in time, HSA has expedited the review of remdesivir given the urgent public health need during the COVID-19 pandemic'

Singapore has approved the use of Gilead Sciences Inc’s antiviral drug Remdesivir for the treatment of severely ill patients with COVID-19 infection.

Remdesivir is the first drug shown to be effective against the novel coronavirus in human trials, with South Korea, Japan, India and the United States having already approved the drug for emergency use.

Singapore’s Health Sciences Authority (HSA) on Wednesday said the conditional approval would allow treatment of adult patients if they have low blood oxygen levels, require supplemental oxygen or intensive breathing support.

“Although the data on its efficacy and safety is very limited at this point in time, HSA has expedited the review of remdesivir given the urgent public health need during the COVID-19 pandemic,” HSA said in statement.

Clinical studies involving the drug are being closely watched as nations look for treatments for the disease that has infected more than 7 million people and killed over 400,000 globally.

Tiny city-state Singapore has nearly 39,000 COVID-19 cases, one of the highest tallies in Asia due to mass outbreaks in cramped migrant worker dormitories, but only 25 people have died and only three patients are currently in critical condition.

Remdesivir prevented lung disease in macaque monkeys infected with the new coronavirus, according to a study published on Tuesday. In a U.S.-run clinical trial released in late April, remdesivir reduced hospitalization stays by 31%, or about four days, compared to a placebo.

122
Facebook 117
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail